BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10976394)

  • 1. Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.
    Woo KT; Lau YK
    Ann Acad Med Singap; 2000 May; 29(3):383-7. PubMed ID: 10976394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
    Woo KT; Lau YK; Chan CM; Wong KS
    Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT; Lau YK; Wong KS; Chiang GS
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
    Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
    Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
    Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
    Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria.
    Moriyama T; Kitamura H; Ochi S; Izumi M; Yokoyama K; Yamauchi A; Ueda N; Kamada T; Imai E
    J Am Soc Nephrol; 1995 Dec; 6(6):1676-8. PubMed ID: 8749698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
    Lee YJ; Tsai JC
    Metabolism; 2001 Nov; 50(11):1346-50. PubMed ID: 11699055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of angiotensin-converting enzyme gene polymorphism on the anti-proteinuria efficacy of angiotensin-converting enzyme inhibitor in Han nationality of southern Sichuan province in China].
    Liu J; Wang M; Liu Q; Li Y; Peng B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):204-5. PubMed ID: 15793787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
    Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
    Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
    Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
    Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
    J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
    Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
    Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen).
    Ruggenenti P; Perna A; Zoccali C; Gherardi G; Benini R; Testa A; Remuzzi G
    J Am Soc Nephrol; 2000 Jan; 11(1):88-96. PubMed ID: 10616844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria: clinical signficance and basis for therapy.
    Woo KT; Lau YK
    Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.
    Haas M; Yilmaz N; Schmidt A; Neyer U; Arneitz K; Stummvoll HK; Wallner M; Auinger M; Arias I; Schneider B; Mayer G
    Kidney Blood Press Res; 1998; 21(1):66-9. PubMed ID: 9661139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.